NYSE:PFE »

  • Business Wire

    Pfizer Inc. (NYSE:PFE) and Merck & Co. Inc. (NYSE:MRK) , known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizer’s crizotinib (XALKORI(R)) with Merck’s investigational anti-PD-1 antibody pembrolizumab, in a Phase 1b clinical study evaluating

  • David Becker

    Sterling broke out of its current range on Monday and is poised to test higher levels as traders look forward to Tuesday’s look at Growth Domestic Product. Reports that large hedge funds were purchasing both Cable and the Euro despite continued talk of sanction for Russia have caught the FX market by surprise. With Pfizer

  • Stocks on the US exchanges fluctuated throughout the day before pulling ahead in the late hours of New York trade, as market participants mulled over the Federal Reserve’s next course of action. Most economists now believe the central bank will continue to purchase bonds at a pace of $85 billion per month until next spring,

  • US stocks maintained their upward momentum, with the Standard & Poor’s 500 Index extending its record high. The benchmark index was supported after weak economic data reassured market participants the Federal Reserve won’t reign in record stimulus at this time. The Federal Open Market Committee is coalescing in Washington for a two-day meeting to discuss

  • Stocks on the American exchange continued their upward momentum, as Senate Democrats and Republicans inched closer to a resolution that would end the government shutdown and avoid breaching the debt limit. Both sides expressed a great deal of optimism in reaching a deal before the October 17 deadline, when the United States government will have

Page 10 of 10« First...45678910